Why Soliton Sold Off on Good News from the FDA

As highly anticipated, medical device maker Soliton (SOLY) announced the company received approval from the FDA for the cellulite indication of its Rapid Acoustic Pulse (“RAP”) technology. SOLY initially opened on February 1st with a 17.3% gain, but the stock ended the day with a 3.6% gain. Why did Soliton sell off after this good … Read more

Sellers Followed Through On Resolution of Bearish Divergence – Above the 40 (January 29, 2021)

Stock Market Commentary After the recent bearish divergence resolved to the downside, the stock market rebounded sharply. Volatility was over-extended and my favorite breadth indicator plunged at an extreme rate. In that context, the stock market’s subsequent bounce made sense as relief from extreme conditions. The sellers followed through on the resolution of bearish divergence … Read more

How to Understand the Price Action From Stock Offerings

A stock offering is an opportunity for a publicly traded company to raise money for corporate investment, strengthening the balance sheet, and/or funding operations. Insider shareholders can also sell their shares to the public through a stock offering. Like any seller, these parties want to maximize the money generated from the stock sales. As a … Read more

Micro-Bubbles Slicing Through Overbought Trading Signals – Above the 40 (January 22, 2021)

Stock Market Commentary The stock market gapped up and never looked back in the wake of the Presidential Inauguration. Subsequently, buyers produced mixed follow-through for two days. Big cap tech defied the narrative of a rotation into value and industrial names by delivering the most convincing follow-through. A third drop from overbought conditions in a … Read more

Soliton Stock: Eagerly Anticipating News from the FDA

Almost two years have passed since I first wrote about the promise of Soliton for tattoo removal. Since then, the company expanded its indications to include cellulite removal. Soliton (SOLY) is currently rallying apparently in anticipation of news from the FDA on the cellulite application. Next, the coronavirus pandemic delayed plans for a 2020 launch. … Read more

Sellers Weaken the Stock Market’s Hold On Overbought Conditions – Above the 40 (December 29, 2020)

AT40 (T2108) dropped toward the overbought threshold of 70%.

Stock Market Commentary The refresher for extended overbought conditions quickly transformed back into a close call. Sellers again created weakening overbought conditions for the stock market with the key indicator hitting the threshold. The minor selling in the major indices may mask a broader deterioration in the technical health of the stock market. Unlike the … Read more

GoodRx: A Healthy Recovery from An Amazon Panic

The Amazon Panic An “Amazon Panic” describes a rush of selling in the stocks of companies potentially impacted by a new initiative from Amazon.com (AMZN). Invariably, the dust settles, the panic subsides, and buyers pick up the pieces. The whirlwind is a short-term, quick trigger reaction to a world shattered by Amazon. An Amazon Panic … Read more

The Stock Market Stretches Into An Extended Overbought Rally – Above the 40 (December 4, 2020)

Stock Market Statistics AT40 = 79.6% of stocks are trading above their respective 40-day moving averages (DMAs) (Day #10 overbought) AT200 = 77.7% of stocks are trading above their respective 200DMAs (7 1/2 year high) VIX = 20.8 Short-term Trading Call: neutral Stock Market Commentary A week ago, the overbought stock market stretched for a … Read more

Soliton Stock Tries Bottoming Ahead of Key Industry Event

Soliton Stock While the general stock market sold off in September, medical device company Soliton (SOLY) finally came alive. So far, the momentum continues into this month with Soliton’s stock closing at a 2 1/2 month high. SOLY is forming a potential bottom with a higher low and two higher highs including a breakout above … Read more

The Stock Market’s Garden Grows More Weeds In Sell-Off – Above the 40 (September 8, 2020)

Stock Market Statistics AT40 = 42.5% of stocks are trading above their respective 40-day moving averages (DMAs) (2-month low)AT200 = 42.1% of stocks are trading above their respective 200DMAs (2 1/2 week low)VIX = 31.5Short-term Trading Call: cautiously bearish Stock Market Commentary The swift stock market sell-off took a fresh turn for the worse. AT200 … Read more